These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23077877)

  • 21. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study.
    Silva CA; Hilário MO; Febrônio MV; Oliveira SK; Terreri MT; Sacchetti SB; Sztajnbok FR; Marini R; Quintero MV; Bica BE; Pereira RM; Bonfá E; Ferriani VP; Robazzi TC; Magalhães CS
    Lupus; 2007; 16(7):531-6. PubMed ID: 17670855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.
    Hassan AA; Habib HM; Eissa AA
    Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
    Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
    Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accrual of organ damage over time in patients with systemic lupus erythematosus.
    Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
    J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review.
    Alonso MD; Martinez-Vazquez F; de Teran TD; Miranda-Filloy JA; Dierssen T; Blanco R; Gonzalez-Juanatey C; Llorca J; Gonzalez-Gay MA
    Lupus; 2012 Sep; 21(10):1135-48. PubMed ID: 22652632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Sousa S; Gonçalves MJ; Inês LS; Eugénio G; Jesus D; Fernandes S; Terroso G; Romão VC; Cerqueira M; Raposo A; Couto M; Nero P; Sequeira G; Nóvoa T; Melo Gomes JA; da Silva JC; Costa L; Macieira C; Silva C; Silva JA; Canhão H; Santos MJ
    Rheumatol Int; 2016 Jul; 36(7):955-60. PubMed ID: 26979603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S; Harper J; Kiely PD
    Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
    Merola JF; Chang CA; Sanchez MR; Prystowsky SD
    J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Nived O; Sturfelt G; Truedsson L; Ivars F; Leanderson T; Bengtsson AA
    Rheumatology (Oxford); 2013 Nov; 52(11):2048-55. PubMed ID: 23942785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and serologic factors associated with lupus pleuritis.
    Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
    J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
    Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
    Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.